Robeco Institutional Asset Management B.V. Has $13.79 Million Stock Position in Danaher Corporation (NYSE:DHR)

Robeco Institutional Asset Management B.V. reduced its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 10.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,276 shares of the conglomerate's stock after selling 7,631 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Danaher were worth $13,792,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. GHP Investment Advisors Inc. increased its stake in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at $27,000. Rialto Wealth Management LLC acquired a new stake in Danaher in the fourth quarter valued at approximately $34,000. Hurley Capital LLC acquired a new position in Danaher during the fourth quarter worth $34,000. Finally, Dunhill Financial LLC lifted its stake in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after buying an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In related news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president owned 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Danaher Stock Performance

Shares of Danaher stock traded down $1.40 during trading hours on Monday, hitting $197.40. 4,537,425 shares of the company were exchanged, compared to its average volume of 3,509,668. The stock has a market capitalization of $141.27 billion, a price-to-earnings ratio of 38.33, a P/E/G ratio of 2.79 and a beta of 0.77. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70. The business has a 50-day moving average of $194.84 and a 200-day moving average of $208.15.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's payout ratio is 24.85%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of recent research reports. Wolfe Research reduced their target price on shares of Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research report on Monday, April 7th. Wells Fargo & Company lowered their target price on Danaher from $240.00 to $210.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 23rd. TD Cowen increased their price target on Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a report on Wednesday, April 23rd. UBS Group reduced their price objective on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Four analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and an average price target of $248.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.